<DOC>
	<DOCNO>NCT02351843</DOCNO>
	<brief_summary>The purpose study demonstrate clinical feasibility low amplitude electroconvulsive therapy ( ECT ) reduce , possibly eliminate side effect ECT lower strength ECT stimulus conventional 800 mA 500 mA . Low amplitude ECT could potentially reduce risk associate ECT preserve unparalleled efficacy . This novel development would remove key obstacle allow wide adoption ECT safe effective therapy .</brief_summary>
	<brief_title>Efficacy Safety Low Amplitude Electroconvulsive Therapy</brief_title>
	<detailed_description />
	<criteria>1 . Male female subject , age 1870 2 . DSMIVTR diagnosis major depressive episode unipolar bipolar disorder , confirm MINIPLUS 3 . MMSE total score &gt; 26 4 . Referred ECT 5 . Competent provide inform consent 6 . Able read comprehend English 1 . Lifetime history schizophrenia , schizoaffective disorder , mental retardation 2 . Current neurostimulation treatment ( e.g. , ECT , magnetic seizure therapy , transcranial magnetic stimulation , vagus nerve stimulation , deep brain stimulation ) 3 . Current alcohol abuse dependence within past 6 month 4 . Current substance abuse dependence within past 6 month 5 . History central nervous system ( CNS ) disease 6 . Current diagnosis dementia delirium 7 . MoCA total score &lt; 26 8 . Current visual , auditory , motor impairment compromise ability complete evaluation 9 . Patients intracranial implant 10 . MRI contraindication : pregnancy , implanted metal , claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>